• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非小细胞肺癌患者免疫炎症指标及营养风险指数与预后的相关性

Correlation of immune inflammatory indices and nutritional risk index with prognosis in patients with non-small cell lung cancer.

作者信息

Shi Zhongmiao, Zheng Dawei, Tang Xiaowan, Du Youyi

机构信息

Department of Cardio-Thoracic Surgery, Shaoxing Shangyu Hospital of Traditional Chinese Medicine Shaoxing 312300, Zhejiang, China.

Department of Respiratory, Nanyang Central Hospital Nanyang 473000, Henan, China.

出版信息

Am J Transl Res. 2023 Jun 15;15(6):4100-4109. eCollection 2023.

PMID:37434819
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10331693/
Abstract

OBJECTIVE

To investigate the relationship of lymphocyte-to-monocyte ratio (LMR), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and nutritional risk index (NRI) with the prognosis of non-small cell lung cancer (NSCLC).

METHODS

The clinical data of 400 NSCLC patients undergoing surgery at Shaoxing Shangyu Hospital of Traditional Chinese Medicine from January 2019 to June 2022 were collected for this retrospective analysis. The optimal cutoff values for NLR, PLR, LMR and NRI were determined using receiver operating characteristic (ROC) curves. The patients were grouped according to the optimal cutoff values, and the clinicopathological characteristics were compared between groups. The Kaplan-Meier survival curve and Cox risk model were used to identify the independent risk factors affecting the prognosis of patients with NSCLC. A nomogram risk prediction model was constructed and its effectiveness was verified.

RESULTS

ROC curve analysis revealed that the area under the curve (AUC) values for NLR, PLR, LMR and NRI in predicting overall survival of NSCLC patients were 0.827, 0.753, 0.719 and 0.770, respectively. The optimal cutoff values for NLR, PLR, LMR and NRI were 2.49, 126.32, 3.02 and 89, respectively. Survival analysis found that the survival time was shorter in patients with NLR>2.49, PLR>126.32, LMR>3.02 and NRI≤89. Results from Cox model indicated that TNM staging, NLR>2.49, LMR>3.02, NRI≤89, surgical method, intraoperative blood loss, postoperative complication, and adjuvant chemotherapy were risk factors affecting the prognosis of NSCLC patients. A nomogram was constructed based on the results of multivariate analysis. The AUC of the nomogram was 0.967 (95% CI: 0.943-0.992) and 0.948 (95% CI: 0.874-1) in the training set and the test set, respectively. The C-index was 0.90 and 0.89, respectively. The calibration curve demonstrated good agreement between the predicted values of the nomogram and the actual observed values.

CONCLUSION

NLR, LMR and NRI are significant predictors of the prognosis of patients with NSCLC. NLR>2.49, LMR>3.02, and NRI≤89 are risk factors for the prognosis of NSCLC patients.

摘要

目的

探讨淋巴细胞与单核细胞比值(LMR)、中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)及营养风险指数(NRI)与非小细胞肺癌(NSCLC)预后的关系。

方法

收集2019年1月至2022年6月在绍兴上虞中医医院接受手术的400例NSCLC患者的临床资料进行回顾性分析。采用受试者工作特征(ROC)曲线确定NLR、PLR、LMR和NRI的最佳截断值。根据最佳截断值对患者进行分组,并比较组间的临床病理特征。采用Kaplan-Meier生存曲线和Cox风险模型确定影响NSCLC患者预后的独立危险因素。构建列线图风险预测模型并验证其有效性。

结果

ROC曲线分析显示,NLR、PLR、LMR和NRI预测NSCLC患者总生存的曲线下面积(AUC)值分别为0.827、0.753、0.719和0.770。NLR、PLR、LMR和NRI的最佳截断值分别为2.49、126.32、3.02和89。生存分析发现,NLR>2.49、PLR>126.32、LMR>3.02和NRI≤89的患者生存时间较短。Cox模型结果表明,TNM分期、NLR>2.49、LMR>3.02、NRI≤89、手术方式、术中出血量、术后并发症及辅助化疗是影响NSCLC患者预后的危险因素。根据多因素分析结果构建列线图。列线图在训练集和测试集的AUC分别为0.967(95%CI:0.943-0.992)和0.948(95%CI:0.874-1)。C指数分别为0.90和0.89。校准曲线显示列线图预测值与实际观察值之间具有良好的一致性。

结论

NLR、LMR和NRI是NSCLC患者预后的重要预测指标。NLR>2.49、LMR>3.02和NRI≤89是NSCLC患者预后的危险因素。

相似文献

1
Correlation of immune inflammatory indices and nutritional risk index with prognosis in patients with non-small cell lung cancer.非小细胞肺癌患者免疫炎症指标及营养风险指数与预后的相关性
Am J Transl Res. 2023 Jun 15;15(6):4100-4109. eCollection 2023.
2
[Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].[直肠癌患者术前炎症指标与预后的关系及预后列线图预测模型的建立]
Zhonghua Zhong Liu Za Zhi. 2022 May 23;44(5):402-409. doi: 10.3760/cma.j.cn112152-20200630-00612.
3
Prognostic significance of combined preoperative platelet-to-lymphocyte ratio and lymphocyte-to-monocyte ratio in patients undergoing surgery with stage IB non-small-cell lung cancer.术前血小板与淋巴细胞比值和淋巴细胞与单核细胞比值联合对ⅠB期非小细胞肺癌手术患者的预后意义
Cancer Manag Res. 2018 Nov 8;10:5411-5422. doi: 10.2147/CMAR.S177320. eCollection 2018.
4
Prognostic value of multiple immune inflammatory markers in diffuse large B-cell lymphoma.多种免疫炎症标志物在弥漫性大B细胞淋巴瘤中的预后价值
Am J Transl Res. 2023 Apr 15;15(4):2610-2621. eCollection 2023.
5
Inflammation-based prognostic scoring system for predicting the prognosis of advanced small cell lung cancer patients receiving anlotinib monotherapy.基于炎症的预后评分系统,用于预测接受安罗替尼单药治疗的晚期小细胞肺癌患者的预后。
J Clin Lab Anal. 2022 Dec;36(12):e24772. doi: 10.1002/jcla.24772. Epub 2022 Nov 28.
6
[Correlation between preoperative inflammatory biomarkers and postoperative pneumonia or long-term prognosis in patients with esophageal cancer after neoadjuvant therapy].新辅助治疗后食管癌患者术前炎症生物标志物与术后肺炎或长期预后的相关性
Zhonghua Wai Ke Za Zhi. 2021 Aug 1;59(8):660-666. doi: 10.3760/cma.j.cn112139-20210201-00060.
7
Diagnostic and prognostic role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and lymphocyte/monocyte ratio in patients with osteosarcoma.中性粒细胞/淋巴细胞比值、血小板/淋巴细胞比值和淋巴细胞/单核细胞比值在骨肉瘤患者中的诊断和预后作用。
Jt Dis Relat Surg. 2021;32(2):489-496. doi: 10.52312/jdrs.2021.79775. Epub 2021 Jun 11.
8
Prognostic Value of Peripheral Inflammatory Markers in Preoperative Mucosal Melanoma: A Multicenter Retrospective Study.外周炎症标志物在术前黏膜黑色素瘤中的预后价值:一项多中心回顾性研究
Front Oncol. 2019 Oct 9;9:995. doi: 10.3389/fonc.2019.00995. eCollection 2019.
9
Diagnostic value of preoperative inflammatory markers in patients with glioma: a multicenter cohort study.术前炎症标志物对胶质瘤患者的诊断价值:一项多中心队列研究。
J Neurosurg. 2018 Sep;129(3):583-592. doi: 10.3171/2017.3.JNS161648. Epub 2017 Nov 3.
10
Preoperative Neutrophil-Lymphocyte Ratio (NLR)-Binding Fibrinogen-Albumin Ratio (FAR) Is Superior to Platelet-Lymphocyte Ratio (PLR)-Binding Fibrinogen-Albumin Ratio (FAR) and Lymphocyte-Monocyte (LMR)-Binding Fibrinogen-Albumin Ratio (FAR) as Predictors of Survival in Surgical Patients with Colorectal Adenocarcinoma.术前中性粒细胞-淋巴细胞比值(NLR)-结合纤维蛋白原-白蛋白比值(FAR)优于血小板-淋巴细胞比值(PLR)-结合纤维蛋白原-白蛋白比值(FAR)和淋巴细胞-单核细胞(LMR)-结合纤维蛋白原-白蛋白比值(FAR),可作为结直肠腺癌手术患者生存的预测指标。
Med Sci Monit. 2023 Mar 30;29:e939442. doi: 10.12659/MSM.939442.

引用本文的文献

1
Efficacy and safety of first-line chemotherapy combined with immune checkpoint inhibitors for extensive-stage small cell lung cancer patients: a real-world propensity score matching study.一线化疗联合免疫检查点抑制剂治疗广泛期小细胞肺癌患者的疗效与安全性:一项真实世界倾向评分匹配研究
Front Immunol. 2025 Aug 13;16:1562458. doi: 10.3389/fimmu.2025.1562458. eCollection 2025.
2
Association between nutritional risk and clinical outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重期患者营养风险与临床结局的相关性
Am J Transl Res. 2025 Jul 25;17(7):5746-5756. doi: 10.62347/MCZH5861. eCollection 2025.
3
Prognostic value of immunoinflammatory indicators and tumor markers for first-line chemotherapy in patients with non-small cell lung cancer.免疫炎症指标和肿瘤标志物对非小细胞肺癌患者一线化疗的预后价值
Am J Cancer Res. 2025 Jul 15;15(7):3209-3218. doi: 10.62347/ZBGU2008. eCollection 2025.
4
Nutritional risk index in hepatitis B virus-related liver cancer: Infection prediction and prognosis.乙型肝炎病毒相关肝癌的营养风险指数:感染预测与预后
World J Gastrointest Oncol. 2025 Jul 15;17(7):105286. doi: 10.4251/wjgo.v17.i7.105286.
5
Prognostic value of neutrophil-to-lymphocyte ratio and CA 19-9 in overall survival of patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.中性粒细胞与淋巴细胞比值及CA 19-9对接受减瘤手术及腹腔热灌注化疗的结直肠癌腹膜转移患者总生存期的预后价值
World J Surg Oncol. 2025 Jun 6;23(1):220. doi: 10.1186/s12957-025-03873-4.
6
Correlation between gut microbiota characteristics and non-small cell lung cancer based on macrogenomics sequencing.基于宏基因组测序的肠道微生物特征与非小细胞肺癌的相关性。
Hereditas. 2024 Aug 27;161(1):26. doi: 10.1186/s41065-024-00328-w.
7
Exploring Inflammatory Parameters in Lung Cancer Patients: A Retrospective Analysis.探索肺癌患者的炎症参数:一项回顾性分析。
J Pers Med. 2024 May 22;14(6):552. doi: 10.3390/jpm14060552.
8
The prognostic value and model construction of inflammatory markers for patients with non-small cell lung cancer.炎症标志物对非小细胞肺癌患者的预后价值及模型构建。
Sci Rep. 2024 Mar 30;14(1):7568. doi: 10.1038/s41598-024-57814-4.

本文引用的文献

1
The predictive value of neutrophil-to-lymphocyte ratio for overall survival and pathological complete response in breast cancer patients receiving neoadjuvant chemotherapy.中性粒细胞与淋巴细胞比值对接受新辅助化疗的乳腺癌患者总生存和病理完全缓解的预测价值
Front Oncol. 2023 Jan 16;12:1065606. doi: 10.3389/fonc.2022.1065606. eCollection 2022.
2
Identification of serum MiRNAs as candidate biomarkers for non-small cell lung cancer diagnosis.血清 miRNAs 作为非小细胞肺癌诊断候选生物标志物的鉴定。
BMC Pulm Med. 2022 Dec 16;22(1):479. doi: 10.1186/s12890-022-02267-6.
3
Preoperative neutrophil-lymphocyte ratio/platelet-lymphocyte ratio: A potential and economical marker for renal cell carcinoma.术前中性粒细胞-淋巴细胞比值/血小板-淋巴细胞比值:肾癌的一种有潜力且经济的标志物。
J Cancer Res Ther. 2022 Oct-Dec;18(6):1635-1639. doi: 10.4103/jcrt.JCRT_482_20.
4
Prognostic value of the modified systemic inflammation score in non-small-cell lung cancer with brain metastasis.改良全身炎症评分在非小细胞肺癌脑转移中的预后价值。
Cancer Cell Int. 2022 Oct 14;22(1):320. doi: 10.1186/s12935-022-02704-w.
5
Associations of Overall Survival with Geriatric Nutritional Risk Index in Patients with Advanced Pancreatic Cancer.老年营养风险指数与晚期胰腺癌患者总生存的相关性。
Nutrients. 2022 Sep 15;14(18):3800. doi: 10.3390/nu14183800.
6
Prognostic Value of Geriatric Nutritional Risk Index for Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.老年营养风险指数对非小细胞肺癌患者预后的预测价值:系统评价和荟萃分析。
Lung. 2022 Oct;200(5):661-669. doi: 10.1007/s00408-022-00567-6. Epub 2022 Sep 16.
7
Non-small cell lung cancer in China.中国的非小细胞肺癌。
Cancer Commun (Lond). 2022 Oct;42(10):937-970. doi: 10.1002/cac2.12359. Epub 2022 Sep 8.
8
Prognostic value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in laryngeal cancer: What should we expect from a meta-analysis?中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值在喉癌中的预后价值:我们能从一项荟萃分析中得到什么?
Front Oncol. 2022 Aug 10;12:945820. doi: 10.3389/fonc.2022.945820. eCollection 2022.
9
Geriatric Nutritional Risk Index and Survival of Patients With Colorectal Cancer: A Meta-Analysis.老年营养风险指数与结直肠癌患者的生存:一项荟萃分析。
Front Oncol. 2022 Jun 30;12:906711. doi: 10.3389/fonc.2022.906711. eCollection 2022.
10
Targeted Therapy and Immunotherapy in Early-Stage Non-Small Cell Lung Cancer: Current Evidence and Ongoing Trials.早期非小细胞肺癌的靶向治疗和免疫治疗:当前证据和正在进行的试验。
Int J Mol Sci. 2022 Jun 29;23(13):7222. doi: 10.3390/ijms23137222.